Document is current
Any future updates will be listed below
-
Authors
Nikkola, Veera
Alakoski, Anna
Mecklin, Jukka-Pekka
Seppälä, Toni T.
Nikkola, Jussi
Schrader, Kashmintan
- License Information
-
More Information
Article History
Received: 25 June 2025
Accepted: 22 October 2025
First Online: 2 December 2025
Declarations
:
: AA reports receiving an honorarium from AbbVie and MSD for lectures on skin cancers. TTS reports consultation fees from Amgen, Tillots Pharma, Orion Pharma, Nouscom and Mehiläinen and holds a position on the Clinical Advisory Board and minor shares in Lynsight Ltd. KS reports institutional grants and lecture honoraria from AstraZeneca and Merck; is a coinventor on a patent for a parent-of-origin method held by PHSA; serves as a medical advisor, shareholder, and stock option holder in Genetics Adviser; and is a cofounder of Evident Genomics. The other authors have no competing interests to declare.
